Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antibiotic Resistance Market
Antibiotic Resistance Market Share
- Report ID: GMI6499
- Published Date: Aug 2023
- Report Format: PDF
Antibiotic Resistance Market Share
The key players in the antibiotic resistance market are :
- ACHAOGEN, INC.
- Basilea Pharmaceutica Ltd.
- MELINTA THERAPEUTICS
- Tetraphase Pharmaceuticals, Inc.
- Theravance Biopharma
- WOCKHARDT
- Entasis therapeutics
- Paratek Pharmaceuticals
- Inc., Seres Therapeutics
- AbbVie, Inc.,
- Merck & Co. Inc.
- and Pfizer, Inc.
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Frequently Asked Questions (FAQ) :
Antibiotic resistance industry size was USD 8.2 billion in 2022 and will reach USD 13.6 billion by the end of 2032 due to the rising investments in research and development along with the increasing global public health concern and awareness.
The hospital pharmacies distribution channel segment held 54% share of the antibiotic resistance industry in 2022 due to the surging need for ensuring that antibiotics are prescribed properly as per the clinical need, susceptibility data, and guidelines.
North America antibiotic resistance market size may record USD 5.5 billion by 2032 driven by the surging government support and fundings in the region
Some of the prominent antibiotic resistance firms are MELINTA THERAPEUTICS, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, WOCKHARDT, Entasis therapeutics, Paratek Pharmaceuticals, Inc., Seres Therapeutics, AbbVie, Inc., Merck & Co. Inc., and Pfizer, Inc
Antibiotic Resistance Market Scope
×
Get a free sample of
Antibiotic Resistance Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below